tryptoline has been researched along with Idiopathic Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López-Rivadulla Lamas, M; Méndez-Alvarez, E; Quiñoá-Cabana, E; Riguera-Vega, R; Sánchez-Sellero, I; Soto-Otero, R | 1 |
| Cruz-Landeira, A; López-Rivadulla Lamas, M; Méndez-Alvarez, E; Sánchez-Sellero, I; Soto-Otero, R | 1 |
2 other study(ies) available for tryptoline and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Studies on the interaction between 1,2,3,4-tetrahydro-beta-carboline and cigarette smoke: a potential mechanism of neuroprotection for Parkinson's disease.
Topics: Animals; Brain; Carbolines; Drug Interactions; Gas Chromatography-Mass Spectrometry; Humans; Male; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Nicotiana; Parkinson Disease; Plants, Toxic; Rats; Rats, Sprague-Dawley; Smoke; Solutions | 1998 |
Reduction of rat brain levels of the endogenous dopaminergic proneurotoxins 1,2,3,4-tetrahydroisoquinoline and 1,2,3,4-tetrahydro-beta-carboline by cigarette smoke.
Topics: Animals; Brain; Carbolines; Dopamine; Isoquinolines; Male; Neurotoxins; Parkinson Disease; Rats; Rats, Sprague-Dawley; Smoking; Tetrahydroisoquinolines | 2001 |